Effect of Skanlab Regarding Knee Arthrosis

September 27, 2016 updated by: Hilde Sylliaas, Oslo Metropolitan University
The purpose is to find out the effect of Skanlab at knee arthrosis.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The patients diagnosed with knee arthrosis will be treated With Skanlab twice a week for four weeks.

Study Type

Interventional

Enrollment (Anticipated)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Norway
      • Oslo, Norway, 0130
        • Recruiting
        • Oslo and Akershus University college of applied science
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • knee arthrosis in one or both legs

Exclusion Criteria:

  • Pacemaker
  • infusion pump
  • cancer
  • diabetes
  • pregnancy
  • blood clots
  • bacteriological inflammation
  • reduced sensitivity in the treatment area.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Treatment with Skanlab Bodywave
Treatment with Skanlab Bodywave twice a week for four weeks at the affected knee.
Other: Skanlab bodywave
The intervention will be done twice a week
No Intervention: No treatment
Treatment with Skanlab Bodywave without function twice a week for four weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: 15 months
changes in pain
15 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Oslo Metropolitan University

Investigators

  • Study Director: Trine Haugen, Prof, Oslo and Akershus University college of applied science

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

January 1, 2016

Study Completion (Anticipated)

December 1, 2016

Study Registration Dates

First Submitted

October 29, 2015

First Submitted That Met QC Criteria

January 6, 2016

First Posted (Estimate)

January 7, 2016

Study Record Updates

Last Update Posted (Estimate)

September 28, 2016

Last Update Submitted That Met QC Criteria

September 27, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Skanlab

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthrosis

Clinical Trials on Skanlab bodywave

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe